Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo, Eugenie S. Kleinerman, Donna Betcher, Mark L. Bernstein, Ernest Conrad, William Ferguson, Mark Gebhardt, Allen M. Goorin, Michael B. Harris, John Healey, Andrew Huvos, Michael Link, Joseph Montebello, Helen Nadel, Michael Nieder, Judith Sato, Gene Siegal, Michael WeinerRobert Wells, Lester Wold, Richard Womer, Holcombe Grier

Research output: Contribution to journal › Article › peer-review

625 Scopus citations

Fingerprint

Dive into the research topics of 'Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate'. Together they form a unique fingerprint.

Medicine & Life Sciences